AIGH Capital Management LLC purchased a new position in shares of Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 300,000 shares of the company’s stock, valued at approximately $916,000. AIGH Capital Management LLC owned 5.79% of Regentis Biomaterials as of its most recent filing with the Securities and Exchange Commission.
Regentis Biomaterials Trading Down 1.6%
Shares of RGNT stock opened at $3.58 on Thursday. Regentis Biomaterials Ltd. has a fifty-two week low of $1.23 and a fifty-two week high of $15.50. The company has a 50-day moving average price of $2.94.
Regentis Biomaterials Company Profile
Read More
- Five stocks we like better than Regentis Biomaterials
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Regentis Biomaterials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regentis Biomaterials and related companies with MarketBeat.com's FREE daily email newsletter.
